Advertisement

Irritable Bowel Syndrome Self Help and Support Group
a trusted community for IBS and Digestive Health sufferers

IBS Self Help and Support Group Forums - IBSgroup.org: Google- Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover - BusinessWeek - IBS Self Help and Support Group Forums - IBSgroup.org

Jump to content


Advertisement

Latest Poll: If you suffer from a chronic pain condition (IBS or other painful condition), how do you feel about your doctor's care?

Find us on Facebook Find us on Twitter Follow us on Pinterest Find us on Google+
Advertisement

Notice:


Topics are automatically created in this forum from a mix of newsfeeds. Please be aware that we have no control over the quality or factual representation of these postings. Some may be informational, whereas some may be wholly inaccurate.

Always research all options and discuss them with your physician before following any specific directive provided in these articles.

To aid other readers, you may rate each article as you review them.

Unfortunately, we have no control over duplicate postings which represent multiple sources of the same article.

Current feeds are: Google, IBS.about.com, Medical News Today, MedicineNet, Pubmed, SmartBrief
Page 1 of 1
  • You cannot start a new topic
  • You cannot reply to this topic

Google- Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover - BusinessWeek Rate Topic: -----

#1 User is offline   Health Reporter 

  • Newsfeeder
  • PipPipPipPip
  • Group: RSS
  • Posts: 39,862
  • Joined: 12-February 08
  • Country:United States

Posted 03 February 2012 - 12:07 PM






RTT News
Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover
BusinessWeek
It found those on lubiprostone had a rate of 27 percent, compared with 19 percent for those on a placebo. Lubiprostone is already approved for chronic constipation in adults and irritable bowel syndrome with constipation in women, and marketed as ...
Sucampo Gains as Bowel Drug Shows Effectiveness in Study: Washington MoverBloomberg
Constipation drug offers more potential for Bethesda's SucampoGazette.Net: Maryland Community News Online
Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid ...MarketWatch (press release)
RTT News
all 25 news articles »


View the full article

Share this topic:


Page 1 of 1
  • You cannot start a new topic
  • You cannot reply to this topic

Advertisement